Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Actinogen Medical ( (AU:ACW) ).
Actinogen Medical Limited has announced that BVF Partners L.P., along with its affiliates, has ceased to be a substantial holder in the company. This development follows a series of on-market sales of fully paid ordinary shares by BVF Partners and its associates, which took place between April 22 and May 19, 2025. The divestment of shares by BVF Partners may impact Actinogen Medical’s shareholder composition and could influence market perceptions of the company’s stock.
More about Actinogen Medical
Average Trading Volume: 8,432,706
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$69.9M
For a thorough assessment of ACW stock, go to TipRanks’ Stock Analysis page.